LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

• DOI: 10.1016/j.annonc.2021.08.2112
• Publication Date: 2021-09-21T22:25:26Z
• Authors: J. Bourhis; Y. Tao; X. Sun; C. Sire; L. Martin; X. Liem; A. Coutte; Y. Pointreau; J. Thariat; J. Miroir; F. Rolland; M-C. Kaminsky; C. Borel; A. Maillard; L. Sinigaglia; J. Guigay; E. Saada-Bouzid; C. Even; A. Aupérin
• Keywords: 03 medical and health sciences; 0302 clinical medicine